Aardvark Therapeutics(AARD.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Aardvark Therapeutics
AARD.US
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
4.623 T
AARD.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    North American Morning Briefing: Stock Futures Slip Amid Mideast, Inflation Pessimism

    MorningStar·
    US
    .DJI
    -0.65%
    US
    .IXIC
    -0.84%
    US
    .SPX
    -0.67%
    MorningStar·
    US
    .DJI
    -0.65%
    US
    .IXIC
    -0.84%
    US
    .SPX
    -0.67%

    FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4

    Tip Ranks·
    US
    AARD
    +0.23%
    Tip Ranks·
    US
    AARD
    +0.23%

    Sector Update: Healthcare Stocks Softer Friday Afternoon

    Fidelity·
    US
    ALMS
    +1.77%
    US
    DXCM
    +2.86%
    US
    SPRY
    -1.78%
    Fidelity·
    US
    ALMS
    +1.77%
    US
    DXCM
    +2.86%
    US
    SPRY
    -1.78%

    <![CDATA[FDA Places Full Clinical Hold on Aardvark Therapeutics’ ARD-101]]>

    Pharmexec·
    US
    AARD
    +0.23%
    Pharmexec·
    US
    AARD
    +0.23%

    12 Health Care Stocks Moving In Friday's Pre-Market Session

    benzinga_article·
    US
    HCWB
    -20.90%
    US
    PIII
    +14.39%
    US
    AARD
    +0.23%
    benzinga_article·
    US
    HCWB
    -20.90%
    US
    PIII
    +14.39%
    US
    AARD
    +0.23%
    © 2026 Longbridge｜Disclaimer